Cholestenoic acid, an endogenous cholesterol metabolite, is a potent γ-secretase modulator-Reference-Cited by-同舟云学术

Cholestenoic acid, an endogenous cholesterol metabolite, is a potent γ-secretase modulator

Published:2015-07-14 Issue:1 Volume:10 Page:
ISSN:1750-1326
Container-title:Molecular Neurodegeneration
language:en
Short-container-title:Mol Neurodegeneration

Author:

Jung Joo In,Price Ashleigh R.,Ladd Thomas B.,Ran Yong,Park Hyo-Jin,Ceballos-Diaz Carolina,Smithson Lisa A.,Hochhaus Günther,Tang Yufei,Akula Rajender,Ba Saritha,Koo Edward H.,Shapiro Gideon,Felsenstein Kevin M.,Golde Todd E.

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology (clinical),Molecular Biology

Link

http://link.springer.com/content/pdf/10.1186/s13024-015-0021-z.pdf

Reference77 articles.

1. Golde TE, Eckman CB, Younkin SG. Biochemical detection of Aβ isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer’s disease. Biochim Biophys Acta. 2000;1502(1):172–87. doi:10.1016/s0925-4439(00)00043-0.

2. Wang R, Sweeney D, Gandy SE, Sisodia SS. The Profile of Soluble Amyloid β Protein in Cultured Cell Media: detection and quantification of amyloid β protein and variants by immunoprecipitation-mass spectrometry. J Biol Chem. 1996;271(50):31894–902.

3. Suzuki N, Cheung TT, Cai XD, Odaka A, Otvos L, Eckman C, et al. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science (New York, NY). 1994;264(5163):1336–40.

4. Younkin S. The role of A beta 42 in Alzheimer's disease. J Physiol Paris. 1998;92:289–92.

5. Kim J, Onstead L, Randle S, Price R, Smithson L, Zwizinski C, et al. Aβ40 Inhibits Amyloid Deposition In Vivo. J Neurosci. 2007;27(3):627–33. doi:10.1523/jneurosci.4849-06.2007.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cholestenoic acid as endogenous epigenetic regulator decreases hepatocyte lipid accumulation in vitro and in vivo;American Journal of Physiology-Gastrointestinal and Liver Physiology;2024-02-01

2. Alzheimer's Disease; Mechanism, Mutations, and Applications of Nano-Medicine;Frontiers in Bioscience-Landmark;2023-10-20

3. White matter injury, cholesterol dysmetabolism, and APP/Abeta dysmetabolism interact to produce Alzheimer’s disease (AD) neuropathology: A hypothesis and review;Frontiers in Aging Neuroscience;2023-02-10

4. Sterols, Oxysterols, and Accessible Cholesterol: Signalling for Homeostasis, in Immunity and During Development;Frontiers in Physiology;2021-10-08

5. Effective sample preparation procedure for the analysis of free neutral steroids, free steroid acids and sterol sulfates in different tissues by GC–MS;The Journal of Steroid Biochemistry and Molecular Biology;2021-07